Statement Of Cash Flows [Abstract]
| Concept |
2023-01-01 to 2023-12-31 |
2022-01-01 to 2022-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) investing activities [abstract] | ||
| Purchase of biological assets |
48,000,000
EUR
|
49,000,000
EUR
|
| Proceeds from sales or maturity of financial instruments, classified as investing activities |
2,000,000
EUR
|
5,000,000
EUR
|
| Cash flows from (used in) financing activities [abstract] | ||
| Dividends paid to equity holders of parent, classified as financing activities |
345,000,000
EUR
|
321,000,000
EUR
|
| Dividends paid to non-controlling interests, classified as financing activities |
7,000,000
EUR
|
9,000,000
EUR
|
| Repayments of non-current borrowings |
—
EUR
|
53,000,000
EUR
|
| Proceeds from current borrowings |
16,000,000
EUR
|
44,000,000
EUR
|
| Repayments of current borrowings |
33,000,000
EUR
|
53,000,000
EUR
|